[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CurrentPartnering: Market Research Reports

Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.

The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.

Publications found: 70
Sort by:
Global Bioinformatics Partnering Terms and Agreements 2014 to 2020 US$ 3,495.00

... companies. Trends in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active deal makers Financial deal terms for bioinformatics The Global Bioinformatics Partnering Terms and Agreements 2014 ...

June 2020 600 pages
Global Hematology Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Hematology Partnering 2014 to 2019 provides the full collection of Hematology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Hematology partnering deals Financial deal terms ...

June 2020 400 pages
Global Genitourinary Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Genitourinary Partnering 2014 to 2019 provides the full collection of Genitourinary disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Genitourinary partnering deals Financial deal terms ...

June 2020 350 pages
Global Gynecology Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... scope Global Gynecology Partnering 2014 to 2019 is intended to provide the reader with an in-depth understanding and access to Gynecology trends and structure of deals entered into by leading companies worldwide. Global Gynecology Partnering 2014 to 2019 ...

June 2020 250 pages
Global Immunology Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Immunology Partnering 2014 to 2019 provides the full collection of Immunology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Immunology partnering deals Financial deal terms ...

June 2020 500 pages
Global Genetic Disorders Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... access to Genetic Disorders trends and structure of deals entered into by leading companies worldwide. Global Genetic Disorders Partnering 2014 to 2019 includes: Trends in Genetic Disorders dealmaking in the biopharma industry since 2014 Analysis of Genetic Disorders deal structure ...

June 2020 350 pages
Global Hospital Care Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... access to Hospital Care trends and structure of deals entered into by leading companies worldwide. Global Hospital Care Partnering 2014 to 2019 includes: Trends in Hospital Care dealmaking in the biopharma industry since 2014 Analysis of Hospital Care deal structure ...

June 2020 550 pages
Global Regenerative Medicine Partnering Terms and Agreements 2014 to 2020 US$ 3,495.00

... access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies. DESCRIPTION The Global Regenerative Medicine Partnering 2014-2019: Deal trends, players ...

June 2020 750 pages
Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020 US$ 3,495.00

... Access to over 640 monoclonal antibodies deal records The leading monoclonal antibodies deals by value since 2014 Includes chimeric mAb, humanized mAb, human mAb and murine mAb deals and alliances since 2014 In Global Monoclonal antibody Partnering Terms and Agreements 2014 to 2098 ...

June 2020 500 pages
Global Diagnostic Imaging Partnering Terms and Agreements 2014 to 2020 US$ 3,495.00

... imaging partnering deals. This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering: Imaging CT Endoscope Molecular and nuclear PET SPECT MRI Ultrasound X ray Angiography Fluoroscopy Mammography This report provides an overview of diagnostic imaging ...

June 2020 350 pages
Global Gene Therapy Partnering Terms and Agreements 2014 to 2020 US$ 3,495.00

... -life gene therapy deals Access to over 220 gene therapy deals The leading gene therapy deals by value since 2014 Most active gene therapy dealmakers since 2014 The leading gene therapy partnering resources In Global Gene Therapy Partnering Terms and ...

June 2020 250 pages
Global Molecular Diagnostics Partnering Terms and Agreements 2014 to 2020 US$ 3,495.00

... due diligence to assess suitability of your proposed deal terms for partner companies Report scope Global Molecular Diagnostics Partnering 2014-2019: Deal trends, players, financials and forecasts is intended ...

June 2020 450 pages
Global Genomics Partnering Terms and Agreements 2014 to 2020 US$ 3,495.00

... , upfronts, milestones and royalties by stage of development Genomics partnering contract documents Top Genomics deals by value The Global Genomics Partnering Terms and Agreements report provides an understanding and ...

June 2020 550 pages
Global Microbiome Partnering Terms and Agreements 2010 to 2020 US$ 3,495.00

... , upfronts, milestones and royalties by stage of development Microbiome partnering contract documents Top Microbiome deals by value The Global Microbiome Partnering Terms and Agreements report provides an understanding and ...

June 2020 150 pages
Global Proteomics Partnering Terms and Agreements 2010 to 2020 US$ 3,495.00

... , upfronts, milestones and royalties by stage of development Proteomics partnering contract documents Top Proteomics deals by value The Global Proteomics Partnering Terms and Agreements report provides an understanding and ...

June 2020 400 pages
Global Biosimilars Partnering Terms and Agreements 2010 to 2020 US$ 3,495.00

... fifty big pharma companies Understand the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies

June 2020 140 pages
Global COVID-19 Partnering - 12 month subscription US$ 2,495.00

SUMMARY The Global COVID-19 Partnering report provides comprehensive understanding and unprecedented access to the COVID-19 partnering deals and agreements entered into by the worlds leading healthca...

June 2020 120 pages
Global Companion Diagnostics Partnering Terms and Agreements 2010-2020 US$ 3,495.00

... Case studies of real-life Companion Diagnostics deals Access to Companion Diagnostics contract documents Leading Companion Diagnostics deals by value since 2014 Most active Companion Diagnostics dealmakers since 2014 In Global Companion Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

May 2020 300 pages
Global Cancer Vaccine Partnering Terms and Agreements 2010-2020 US$ 3,495.00

... Case studies of real-life Cancer Vaccine deals Access to Cancer Vaccine contract documents Leading Cancer Vaccine deals by value since 2014 Most active Cancer Vaccine dealmakers since 2014 In Global Cancer Vaccine Partnering 2014-2019: Deal trends, players, financials and ...

May 2020 200 pages
Global Antibody Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... announced in the healthcare sectors, covering: Antibodies Antibody-drug conjugates Monoclonal antibodies Murine mAb Chimeric mAb Humanized mAb Human aAb Polyclonal Antibodies Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process ...

May 2020 850 pages
Global Infectious Diseases Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies DESCRIPTION Global Infectious Diseases Partnering 2014 to 2019 provides the full collection of Infectious Diseases disease deals signed between ...

May 2020 1000 pages
Global Metabolic Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Metabolic Partnering 2014 to 2019 provides the full collection of Metabolic disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Metabolic partnering deals Financial deal terms ...

May 2020 600 pages
Global Musculoskeletal Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Musculoskeletal Partnering 2014 to 2019 provides the full collection of Musculoskeletal disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Musculoskeletal partnering deals Financial deal terms ...

May 2020 350 pages
Global Oncology Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... , Vomiting, Chemotherapy, Radiotherapy, Adenocarcinoma, Basal cell carcinoma, Bile duct cancer, Bladder cancer, Bone cancer, Brain cancer, Breast cancer, Cervical cancer, Colorectal cancer, Endometrial, Esophageal cancer, Gastric cancer, Head and neck cancer, Kaposi's sarcoma, Kidney cancer, Leukemia, Acute ...

May 2020 2500 pages
Global Antibiotics Partnering Terms and Agreements 2010 to 2020 US$ 3,495.00

... healthcare sectors, covering: Antibiotics Aminoglycosides Cephalosporin Clindamycin Macrolides Penicillin Quinolones Sulfonamides Tetracycline Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into ...

May 2020 250 pages
Global Cancer Diagnostics Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... Case studies of real-life Cancer Diagnostics deals Access to Cancer Diagnostics contract documents Leading Cancer Diagnostics deals by value since 2014 Most active Cancer Diagnostics dealmakers since 2014 In Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players, financials and ...

May 2020 450 pages
Global Orphan Diseases Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... to hundreds of Orphan Diseases deal contract documents Comprehensive access to over 120 Orphan Diseases deal records The leading Orphan Diseases deals by value since 2014 Most active Orphan Diseases dealmakers since 2014 In Global Orphan Diseases Partnering 2014 to 2019, available deals and ...

May 2020 200 pages
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... cancer monoclonal antibody deals by value since 2014 In Cancer Monoclonal Antibody Partnering Terms & Agreements, the available deals are listed by: Company A-Z Headline value Stage of development at signing Deal component type Specific oncology ...

May 2020 300 pages
Global Diagnostics Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... healthcare sectors, covering: Companion Diagnostics Imaging CT Endoscope Molecular and nuclear MRI Ultrasound X-ray PET SPECT Angiography Fluroscopy Mammography In vitro diagnostics Molecular diagnostics Prognostics Theranostics The report provides a detailed ...

May 2020 1000 pages
Global Vaccine Partnering Terms and Agreements 2014-2020: Deal trends, players and financials US$ 3,495.00

... by the big pharma and big biotech companies of the world in terms of deals made. One of the key highlights of the report is that over 450 online deals records of actual vaccine deals ...

May 2020 400 pages
Global Drug Delivery Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... Drug Delivery deals Access to Drug Delivery contract documents Leading Drug Delivery deals by value since 2014 Most active Drug Delivery dealmakers since 2014 In Global Drug Delivery Partnering 2014-2019: Deal ... at signing Deal component type Specific therapy target Technology type Each deal title links ...

May 2020 700 pages
Global Infectious Vaccines Partnering Terms and Agreements 2014 to 2020: Deal trends, players and financials US$ 3,495.00

... 250 infectious vaccines deal records Identify the most active infectious vaccine dealmakers since 2014 The leading infectious vaccines deals by value since 2014 Includes adjuvant deals and alliances since 2014 In Global Infectious Vaccines Partnering Terms ...

May 2020 250 pages
Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... of real-life In Vitro Diagnostics deals Access to In Vitro Diagnostics contract documents Leading In Vitro Diagnostics deals by value since 2014 Most active In Vitro Diagnostics dealmakers since 2014 In Global In Vitro Diagnostics Partnering 2014-2019: Deal trends, players ...

May 2020 300 pages
Global Stem Cell Partnering Terms and Agreements 2010-2020 US$ 3,495.00

... Case studies of real-life Stem Cell deals Access to Stem Cell contract documents Leading Stem Cell deals by value since 2014 Most active Stem Cell dealmakers since 2014 In Global Stem Cell Partnering 2014-2019: Deal trends, players, financials and ...

May 2020 400 pages
Global Artificial Intelligence (AI) Partnering Terms and Agreements 2014 to 2020 US$ 3,495.00

... 200 artificial intelligence deals The leading artificial intelligence deals by value since 2014 Most active artificial intelligence dealmakers since 2014 The leading artificial intelligence partnering resources In Global Artificial Intelligence Partnering Terms and ...

May 2020 250 pages
Global Precision Medicine Partnering Terms and Agreements 2014-2020 US$ 3,495.00

... unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies DESCRIPTION The Global Precision Medicine Partnering 2014-2019 report provides comprehensive understanding ...

May 2020 650 pages
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 US$ 3,495.00

... the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies REPORT SCOPE Global Asset Purchase Deals in Pharma, Biotech and ...

April 2020 600 pages
Global Cardiovascular Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... heart failure, Coronary artery disease, Ductus arteriosus, Fatigue, Hypercholesterolemia, Hypertension, Intermittent claudication, Ischemic heart disease, Limb ischemia, Marfan's Syndrome, Myocardial Infarction, Oedema (excess fluid), Palpitations, Peripheral arterial disease, Thrombus (blood clot), Valvular ...

April 2020 450 pages
Global Central Nervous System Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... Cerebral palsy, Creutzfeldt Jakob disease, Dizziness, Epilepsy, Faints, Falls, Guillain Barre syndrome, Headache, Meningitis (Bacterial, Meningococcal, Pneumococcal), Mycobacterium tuberculosis (TB), Haemophilus influenzae Type B (Hib), Migraine, Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig ...

April 2020 850 pages
Global Dental Partnering 2010-2020: Deal trends, players and financials US$ 3,495.00

... DESCRIPTION Global Dental Partnering 2014 to 2019 provides the full collection of Dental disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Dental partnering deals Financial deal terms ...

April 2020 200 pages
Global Gastrointestinal Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... , Esophagitis, Gastritis, Gastroenteritis, Hemorrhoids (haemorrhoids), Hernia, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Irritable bowel syndrome, Malabsorption, Malnutrition, Pancreatitis, Peptic ulce, Gastric ulcer, Duodenal ulcer, Abdominal pain, Ascites, Bowel movement, Constipation ...

April 2020 300 pages
Global Dermatology Partnering 2014-2020: Deal trends, players and financials US$ 3,495.00

... deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles ...

April 2020 350 pages
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 US$ 3,495.00

... manufacturing and supply deals by value since 2014 Most active manufacturing and supply dealmakers since 2014 The leading manufacturing and supply partnering resources In Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech ...

April 2020 950 pages
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020 US$ 3,495.00

... Current Agreements deals and alliances database, providing easy access to each deal record on demand. The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 ...

April 2020 250 pages
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 US$ 3,495.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

April 2020 400 pages
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020 US$ 3,495.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

April 2020 2500 pages
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 US$ 3,495.00

... DESCRIPTION The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and ...

April 2020 1000 pages
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 US$ 3,495.00

... Joint venture alliances. KEY BENEFITS Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 provides the reader with the following key benefits: In-depth understanding of joint venture partnering deal ...

April 2020 300 pages
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 US$ 3,495.00

... latest licensing agreements announced in the pharmaceutical, biotechnology ... licensing deals by value since 2014 Most active licensing dealmakers since 2014 The leading licensing partnering resources In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals ...

April 2020 2000 pages
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 US$ 3,495.00

... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...

April 2020 750 pages

Filters

Search

Categories

25
20
1
7
4
2
1
1
1
1
2
1
1
1
1
1

Publishers

70

Regions

70

Price

Date

Pages

Offers